GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SHL Telemedicine Ltd (XSWX:SHLTN) » Definitions » COGS-to-Revenue

SHL Telemedicine (XSWX:SHLTN) COGS-to-Revenue : 0.56 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is SHL Telemedicine COGS-to-Revenue?

SHL Telemedicine's Cost of Goods Sold for the six months ended in Dec. 2023 was CHF13.48 Mil. Its Revenue for the six months ended in Dec. 2023 was CHF24.28 Mil.

SHL Telemedicine's COGS to Revenue for the six months ended in Dec. 2023 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. SHL Telemedicine's Gross Margin % for the six months ended in Dec. 2023 was 44.47%.


SHL Telemedicine COGS-to-Revenue Historical Data

The historical data trend for SHL Telemedicine's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SHL Telemedicine COGS-to-Revenue Chart

SHL Telemedicine Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.49 0.50 0.54 0.56

SHL Telemedicine Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.52 0.56 0.56 0.56

SHL Telemedicine COGS-to-Revenue Calculation

SHL Telemedicine's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=27.512 / 49.358
=0.56

SHL Telemedicine's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=13.479 / 24.275
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SHL Telemedicine  (XSWX:SHLTN) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

SHL Telemedicine's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 13.479 / 24.275
=44.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


SHL Telemedicine COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of SHL Telemedicine's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


SHL Telemedicine (XSWX:SHLTN) Business Description

Traded in Other Exchanges
Address
90 Yigal Alon Street, Tel Aviv, ISR, 67891
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world.

SHL Telemedicine (XSWX:SHLTN) Headlines

No Headlines